Beta blockers enhance early diastolic filling in ischaemic heart disease: a radionuclide assessment.
作者信息
Moralidis E, McCurrach G, Martin W, Hutton I
出版信息
Heart. 2001 Oct;86(4):457. doi: 10.1136/heart.86.4.457.
Abstract
摘要
相似文献
1
Beta blockers enhance early diastolic filling in ischaemic heart disease: a radionuclide assessment.
Heart. 2001 Oct;86(4):457. doi: 10.1136/heart.86.4.457.
2
Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy.
Eur Heart J. 2009 Jun;30(12):1501-9. doi: 10.1093/eurheartj/ehp125. Epub 2009 Apr 23.
3
Regional myocardial ischaemia and diastolic dysfunction in hypertensive heart disease.
Eur Heart J. 1993 Nov;14 Suppl J:110-3.
4
5
[Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].
Kardiol Pol. 1992 Dec;37(12):399-403.
6
Impact of duration of ischemia on left ventricular diastolic properties following reperfusion for acute myocardial infarction.
Am J Cardiol. 2011 Aug 1;108(3):348-54. doi: 10.1016/j.amjcard.2011.03.051. Epub 2011 May 19.
7
Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.
Heart. 2005 Nov;91(11):1471-2. doi: 10.1136/hrt.2004.051425.
8
Myocardial viability assessment in regions of left ventricular dysfunction. Part I: Radionuclide imaging and clinical implications.
Nucl Med Commun. 2001 Jun;22(6):607-11. doi: 10.1097/00006231-200106000-00001.
9
10
[Pulmonary uptake of thallium-201 at rest and diastolic function in patients with ischemic cardiopathy and left ventricular dysfunction].
G Ital Cardiol. 1998 Sep;28(9):1005-11.
本文引用的文献
1
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
Circulation. 1999 Aug 24;100(8):793-8. doi: 10.1161/01.cir.100.8.793.
2
Generation of humanized mice susceptible to peptide-induced inflammatory heart disease.
Circulation. 1999 Apr 13;99(14):1885-91. doi: 10.1161/01.cir.99.14.1885.
3
Chlamydia infections and heart disease linked through antigenic mimicry.
Science. 1999 Feb 26;283(5406):1335-9. doi: 10.1126/science.283.5406.1335.
4
Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo.
Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1157-63. doi: 10.1161/01.atv.18.7.1157.
5
Left ventricular diastolic function: physiology, methods of assessment, and clinical significance.
J Nucl Cardiol. 1995 Nov-Dec;2(6):525-43. doi: 10.1016/s1071-3581(05)80045-5.
6
Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.
J Med Microbiol. 1997 Nov;46(11):959-64. doi: 10.1099/00222615-46-11-959.
7
Altered plasma levels of cytokines in patients with ischemic heart disease.
Coron Artery Dis. 1997 Mar-Apr;8(3-4):143-7. doi: 10.1097/00019501-199703000-00004.
8
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Am J Pathol. 1997 May;150(5):1687-99.
9
Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer.
Int J Cancer. 1997 Feb 20;74(1):31-4. doi: 10.1002/(sici)1097-0215(19970220)74:1<31::aid-ijc6>3.0.co;2-1.
10
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
Circulation. 1996 Mar 1;93(5):841-2. doi: 10.1161/01.cir.93.5.841.
Zotero 插件